We are pleased to announce the rollout of the ACORN-HAI-LITE survey, specifically tailored for all sites within the ACORN2 and ACORN-HAI network. This initiative seeks to streamline protocols and boost participation, particularly focusing on the unique …
The ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) Network will be organising our next seminar talk on 4 Oct 2024, 6pm SGT. On behalf of our ADVANCE-ID Network director, Prof David Paterson, and deputy director, Dr …
The World Health Organization (WHO) continues to make significant strides in strengthening the global clinical research ecosystem.Following the successful first Global Clinical Trials Forum (GCTF) held in Geneva in November 2023, WHO recently hosted a stakeholder consultation on 18 …
The mission of ADVANCE-ID is to conduct high-quality clinical trials that have a global impact on management of infections. With the support of a multi-million dollar grant from the Wellcome Trust, ADVANCE-ID seeks expressions of interest …
Two recent publications emphasise the high impact that the ADVANCE-ID team has in the world of AMR. Dr Mo Yin, Deputy Director of ADVANCE-ID, published the results of a landmark clinical trial in Lancet Respiratory Medicine. …
